STOCK TITAN

Planned sale of 6,400 MRK shares valued at $765,920

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An MRK shareholder has filed a notice of intent to sell 6,400 shares of common stock, with an aggregate market value of $765,920, through Morgan Stanley Smith Barney LLC on 02/04/2026 on the NYSE.

The shares to be sold were acquired mainly through restricted stock vesting under a registered plan on several dates in 2024 and through the exercise of 4,000 options on 02/04/2026. The issuer had 2,482,022,536 shares outstanding at the time referenced.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the MRK Rule 144 filing disclose about planned share sales?

The filing discloses a plan to sell 6,400 shares of MRK common stock with an aggregate market value of $765,920. The sale is expected to occur on 02/04/2026 through Morgan Stanley Smith Barney LLC on the NYSE.

How many MRK shares are planned to be sold and at what value?

The shareholder plans to sell 6,400 MRK common shares with an aggregate market value of $765,920. This amount is listed under the securities information section, alongside details of the broker and the NYSE as the trading venue.

How were the MRK shares in this Rule 144 notice acquired?

The shares were acquired mainly through restricted stock vesting under a registered plan on multiple dates in 2024 and through the exercise of options on 02/04/2026. Each acquisition entry includes the date, amount of securities acquired, and payment details.

What does the filing say about MRK shares outstanding?

The document reports 2,482,022,536 shares of common stock outstanding for the issuer. This figure provides context for the planned sale of 6,400 shares, indicating the relative size of the proposed transaction within the total share base.

Which broker will handle the planned MRK share sale under Rule 144?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. The filing also identifies the NYSE as the securities exchange for the transaction.

Does the MRK Rule 144 filer make any representation about non-public information?

Yes. By signing, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, as required by the form.
Merck & Co

NYSE:MRK

MRK Rankings

MRK Latest News

MRK Latest SEC Filings

MRK Stock Data

287.52B
2.48B
0.07%
80.59%
0.95%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
RAHWAY